ER, PgR, Ki67, p27Kip1, and histological grade as predictors of pathological complete response in patients with HER2-positive breast cancer receiving neoadjuvant chemotherapy using taxanes followed by fluorouracil, epirubicin, and cyclophosphamide concomitant with trastuzumab. | 群馬大学図書館 OPAC

Blank Cover Image

twitter facebook Hatena

More Services

QR code of this page

ER, PgR, Ki67, p27Kip1, and histological grade as predictors of pathological complete response in patients with HER2-positive breast cancer receiving neoadjuvant chemotherapy using taxanes followed by fluorouracil, epirubicin, and cyclophosphamide concomitant with trastuzumab.

フォーマット:: 学位論文
責任表示:: 黒住, 献
言語:: 英語
出版情報:: 群馬大学医学系研究科, 2016-03-23
著者名:: 黒住, 献
概要:: Thesis or Dissertation<br />学位記番号：医博甲1570

タイトルが類似している資料

詳細

その他の標題:	HER2陽性乳癌に対するtrastuzumab併用術前化学療法におけるER, PgR, Ki67, p27Kip1, およびhistological gradeの病理学的完全奏効予測因子としての有用性について
受理日:	2016-03-23
URL:	http://hdl.handle.net/10087/10199

内容紹介

Loading contents information

目次情報

Loading contents information

この本を借りた人は、こんな本も借りています

類似資料:

1

2

3

4

5

6

7

8

9

10

11

12

1 学位論文 The pathological complete response and secreted protein acidic and rich in cysteine expression in patients with breast cancer receiving neoadjuvant … 中澤, 祐子群馬大学医学系研究科	7 論文 A Clinicopathologic Study of Breast Cancer Patients during Pregnancy Iijima, Kotaro, Yoshimoto, Masataka, Horiguchi, Jun, Oyama, Tetsunari, Morishita, Yasuo, Kasumi, Fujio, Sakamoto, Goi 北関東医学会
2 学位論文 Phase II study of nab-paclitaxel plus cyclophosphamide plus trastuzumab neoadjuvant chemotherapy in early HER-2-positive breast cancer 荻野, 美里	8 論文 3. Predictive and prognostic role of activated mammalian target of rapamycin (mTOR) in cervical cancer treated with cisplatin-based neoadjuvant … Faried, L. S., Kanuma, T., Nakazato, T, Tamura, T., Minegishi, T., Faried, A., Kuwano, H., Sano, T 北関東医学会
3 学位論文 Early Predictive Value of Non-Response to Docetaxel in Neoadjuvant Chemotherapy in Breast Cancer Using 18F-FDG-PET 平方, 智子群馬大学医学系研究科	9 図書 National Institutes of Health Consensus Development Conference on Adjuvant Chemotherapy and Endocrine Therapy for Breast Cancer : Sept. 9-11, 1985 Lippman, Marc E., National Cancer Institute, National Institute of Health U.S. Dept. of Health and Human Services, National Institute of Health
4 学位論文 SUVmax-based Parameters of FDG-PET/CT Reliably Predict Pathologic Complete Response After Preoperative Hyperthermo-chemoradiotherapy in Rectal Cancer. 村田, 裕人群馬大学医学系研究科	10 論文４．HER2陽性乳癌に対するtrastuzumab併用療法術前化学療法でpCRを得たが,HER2陰性のリンパ節転移が残存した乳癌の１例黒住, 献, 武井, 寛幸, 井上, 賢一, 松本, 広志, 二宮, 淳, 林, 祐二, 久保, 和之, 坪井, 美樹, 大久保, 文恵, 永井, 成勲, 大庭, 華子, 黒住, 昌史, 堀口, 淳, 竹吉, 泉北関東医学会
5 学位論文 High expression of topoisomerase-II predicts favorable clinical outcomes in patients with relapsed small cell lung cancers receiving amrubicin. 三浦, 陽介群馬大学医学系研究科	11 学位論文 Stathmin1 expression is associated with aggressive phenotypes and cancer stem cell marker expression in breast cancer patients Obayashi, Sayaka 群馬大学医学系研究科
6 論文 The Evaluation of Fatigue in Patients with Malignant Lymphoma Receiving Chemotherapy in Japan Hosokawa, Mai, Kanda, Kiyoko 北関東医学会	12 学位論文 The non-cancer specific elevation of the serum squamous cell carcinoma antigen during the post-radiotherapy follow-up of cervical cancer patients 尾池, 妙